Bromodomain and Extra-Terminal (BET) Domain Protein Inhibitors for Solid Tumor Cancers

oleh: Martin V. Nguyen, Lydia Loof, Gerald S. Falchook

Format: Article
Diterbitkan: Innovative Healthcare Institute 2020-02-01

Deskripsi

The bromodomain and extraterminal (BET) domain protein family is involved in the process of transcription of genetic information. The BET protein family includes BRD2, BRD3, BRD4, and bromodomain testis-specific protein. BET protein alterations are associated with some solid tumor cancers, including nuclear protein in testis midline carcinoma. BET protein has a role in carcinogenesis and in the regulation of the cell cycle. A number of BET inhibitors have entered clinical trials. This review discusses the results of BET inhibitor clinical trials in solid tumor cancers.